PMC:7205724 / 1-150
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1 | 29-37 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 131-146 | Body_part | denotes | immunoglobulins | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 29-37 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 88-112 | Chemical | denotes | immunosuppressive agents | http://purl.obolibrary.org/obo/CHEBI_35705 |
LitCovid-sample-MedDRA
Id | Subject | Object | Predicate | Lexical cue | meddra_id |
---|---|---|---|---|---|
T1 | 131-146 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | immunoglobulins | http://purl.bioontology.org/ontology/MEDDRA/10021496 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 88-105 | http://purl.obolibrary.org/obo/IDO_0000610 | denotes | immunosuppressive |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T1 | 29-37 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 39-113 | Sentence | denotes | Rationale and hypothesis for the use of multiple immunosuppressive agents: |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
1 | 29-37 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 7-16 | NN | denotes | treatment |
T2 | 17-25 | NN | denotes | planning |
T3 | 26-28 | IN | denotes | of |
T4 | 29-37 | NN | denotes | COVID-19 |
T5 | 37-38 | -COLON- | denotes | : |
T6 | 39-48 | NN | denotes | Rationale |
T7 | 49-52 | CC | denotes | and |
T8 | 53-63 | NN | denotes | hypothesis |
T9 | 64-67 | IN | denotes | for |
T10 | 68-71 | DT | denotes | the |
T11 | 72-75 | NN | denotes | use |
T12 | 76-78 | IN | denotes | of |
T13 | 79-87 | JJ | denotes | multiple |
T14 | 88-105 | JJ | denotes | immunosuppressive |
T15 | 106-112 | NNS | denotes | agents |
T16 | 112-113 | -COLON- | denotes | : |
T17 | 114-129 | NNS | denotes | Anti-antibodies |
T18 | 129-130 | -COMMA- | denotes | , |
T19 | 131-146 | NNS | denotes | immunoglobulins |
T20 | 146-147 | -COMMA- | denotes | , |
R1 | T2 | T1 | arg1Of | planning,treatment |
R2 | T2 | T3 | arg1Of | planning,of |
R3 | T4 | T3 | arg2Of | COVID-19,of |
R4 | T2 | T5 | arg1Of | planning,: |
R5 | T6 | T7 | arg1Of | Rationale,and |
R6 | T8 | T7 | arg2Of | hypothesis,and |
R7 | T7 | T9 | arg1Of | and,for |
R8 | T11 | T9 | arg2Of | use,for |
R9 | T11 | T10 | arg1Of | use,the |
R10 | T11 | T12 | arg1Of | use,of |
R11 | T15 | T12 | arg2Of | agents,of |
R12 | T15 | T13 | arg1Of | agents,multiple |
R13 | T15 | T14 | arg1Of | agents,immunosuppressive |
R14 | T7 | T16 | arg1Of | and,: |
R15 | T17 | T18 | arg1Of | Anti-antibodies,"," |
R16 | T19 | T18 | arg2Of | immunoglobulins,"," |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 131-146 | Body_part | denotes | immunoglobulins | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 29-37 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 39-113 | Sentence | denotes | Rationale and hypothesis for the use of multiple immunosuppressive agents: |